These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 17804742

  • 1. Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin.
    Son YG, Kim EH, Kim JY, Kim SU, Kwon TK, Yoon AR, Yun CO, Choi KS.
    Cancer Res; 2007 Sep 01; 67(17):8274-84. PubMed ID: 17804742
    [Abstract] [Full Text] [Related]

  • 2. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
    Kim EH, Yoon MJ, Kim SU, Kwon TK, Sohn S, Choi KS.
    Cancer Res; 2008 Jan 01; 68(1):266-75. PubMed ID: 18172319
    [Abstract] [Full Text] [Related]

  • 3. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation.
    Kim JY, Kim EH, Park SS, Lim JH, Kwon TK, Choi KS.
    J Cell Biochem; 2008 Dec 15; 105(6):1386-98. PubMed ID: 18980244
    [Abstract] [Full Text] [Related]

  • 4. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
    Liu X, Yue P, Chen S, Hu L, Lonial S, Khuri FR, Sun SY.
    Cancer Res; 2007 May 15; 67(10):4981-8. PubMed ID: 17510429
    [Abstract] [Full Text] [Related]

  • 5. Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Lee TJ, Um HJ, Min do S, Park JW, Choi KS, Kwon TK.
    Free Radic Biol Med; 2009 Jun 15; 46(12):1639-49. PubMed ID: 19345731
    [Abstract] [Full Text] [Related]

  • 6. Rottlerin sensitizes glioma cells to TRAIL-induced apoptosis by inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.
    Kim EH, Kim SU, Choi KS.
    Oncogene; 2005 Jan 27; 24(5):838-49. PubMed ID: 15531913
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin.
    Schultze K, Böck B, Eckert A, Oevermann L, Ramacher D, Wiestler O, Roth W.
    Apoptosis; 2006 Sep 27; 11(9):1503-12. PubMed ID: 16820965
    [Abstract] [Full Text] [Related]

  • 9. The XIAP inhibitor Embelin enhances TRAIL-mediated apoptosis in malignant glioma cells by down-regulation of the short isoform of FLIP.
    Siegelin MD, Gaiser T, Siegelin Y.
    Neurochem Int; 2009 Nov 27; 55(6):423-30. PubMed ID: 19409438
    [Abstract] [Full Text] [Related]

  • 10. Myricetin sensitizes malignant glioma cells to TRAIL-mediated apoptosis by down-regulation of the short isoform of FLIP and bcl-2.
    Siegelin MD, Gaiser T, Habel A, Siegelin Y.
    Cancer Lett; 2009 Oct 08; 283(2):230-8. PubMed ID: 19398149
    [Abstract] [Full Text] [Related]

  • 11. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH, Jung EM, Lee TJ, Kim SH, Choi YH, Park JW, Park JW, Choi KS, Kwon TK.
    Free Radic Biol Med; 2008 Mar 15; 44(6):1055-68. PubMed ID: 18164688
    [Abstract] [Full Text] [Related]

  • 12. Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation.
    Kim JY, Kim EH, Kim SU, Kwon TK, Choi KS.
    Carcinogenesis; 2010 Mar 15; 31(3):367-75. PubMed ID: 19939880
    [Abstract] [Full Text] [Related]

  • 13. Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.
    Kim EH, Kim HS, Kim SU, Noh EJ, Lee JS, Choi KS.
    Oncogene; 2005 Oct 20; 24(46):6877-89. PubMed ID: 16007142
    [Abstract] [Full Text] [Related]

  • 14. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
    Kauntz H, Bousserouel S, Gossé F, Raul F.
    Apoptosis; 2012 Aug 20; 17(8):797-809. PubMed ID: 22555452
    [Abstract] [Full Text] [Related]

  • 15. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T, Yoshida T, Goda AE, Horinaka M, Yano K, Shiraishi T, Wakada M, Mizutani Y, Miki T, Sakai T.
    Mol Cancer Res; 2008 Dec 20; 6(12):1852-60. PubMed ID: 19074830
    [Abstract] [Full Text] [Related]

  • 16. Genistein enhances proteasomal degradation of the short isoform of FLIP in malignant glioma cells and thereby augments TRAIL-mediated apoptosis.
    Siegelin MD, Siegelin Y, Habel A, Gaiser T.
    Neurosci Lett; 2009 Apr 03; 453(2):92-7. PubMed ID: 19356600
    [Abstract] [Full Text] [Related]

  • 17. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
    Yoshida T, Zhang Y, Rivera Rosado LA, Zhang B.
    Mol Cancer Res; 2009 Nov 03; 7(11):1835-44. PubMed ID: 19843632
    [Abstract] [Full Text] [Related]

  • 18. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis.
    Hetschko H, Voss V, Seifert V, Prehn JH, Kögel D.
    FEBS J; 2008 Apr 03; 275(8):1925-36. PubMed ID: 18341587
    [Abstract] [Full Text] [Related]

  • 19. Epigalocatechin-3-gallate (EGCG) downregulates PEA15 and thereby augments TRAIL-mediated apoptosis in malignant glioma.
    Siegelin MD, Habel A, Gaiser T.
    Neurosci Lett; 2008 Dec 19; 448(1):161-5. PubMed ID: 18948169
    [Abstract] [Full Text] [Related]

  • 20. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
    Shigeno M, Nakao K, Ichikawa T, Suzuki K, Kawakami A, Abiru S, Miyazoe S, Nakagawa Y, Ishikawa H, Hamasaki K, Nakata K, Ishii N, Eguchi K.
    Oncogene; 2003 Mar 20; 22(11):1653-62. PubMed ID: 12642868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.